MetaCap

Gilead Sciences Statistics

NASDAQ: GILDHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

166.43-0.10 (-0.06%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Gilead Sciences by the numbers

Gilead Sciences has a market capitalization of $206.43 billion based on 1.24B shares outstanding. With trailing EPS of $-3.13, Gilead Sciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.8% above its 50-day average and 17.0% above its 200-day average.

Average daily trading volume is 5.98M shares, or about $994.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

GILD valuation vs. peer median

GILD compared with the median of 8 peer companies
MetricGILDPeer medianDifference
Market cap$206.43B$35.88B+475%
Forward P/E16.415.4+7%
Avg. volume5.98M1.81M+231%

Peer median across 8 companies: AMGN, MRNA, ARGX, BIIB, RVMD, BNTX, EXEL, NBIX.

Valuation

Market cap
$206.43B
Price / sales (latest FY)
7.01
EPS (TTM)
$-3.13

Price and trading

Previous close
166.53
Open
168.28
Day range
165.80 – 170.24
52-week range
116.88 – 176.58
52-week change
+31.42%
Beta
—
Volume
7.56M

Dividends and events

Annual dividend
$3.25
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
206.43B
Forward Pe
16.40
Eps
-3.13
Dividend Yield
1.97%
Dividend Rate
3.25
Week52 High
176.58
Week52 Low
116.88
Avg Volume
5.98M
Shares Outstanding
1.24B
Ma50
157.26
Ma200
142.30
Earnings Date
Oct 29, 2026
Pct From52w High
-5.75%
Pct From52w Low
42.39%

Related